Works in Cancer Chemotherapy & Pharmacology, 2014, Vol 73, Issue 1
Results: 29
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Longitudinal assessment of TUBB3 expression in non-small cell lung cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 43, doi. 10.1007/s00280-013-2315-6
- By:
- Publication type:
- Article
A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 163, doi. 10.1007/s00280-013-2334-3
- By:
- Publication type:
- Article
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 113, doi. 10.1007/s00280-013-2327-2
- By:
- Publication type:
- Article
Calcium carbonate does not affect imatinib pharmacokinetics in healthy volunteers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 207, doi. 10.1007/s00280-013-2337-0
- By:
- Publication type:
- Article
Open-label, randomized, single-dose, crossover study to evaluate the pharmacokinetics and safety differences between two docetaxel products, CKD-810 and Taxotere injection, in patients with advanced solid cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 9, doi. 10.1007/s00280-013-2264-0
- By:
- Publication type:
- Article
Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and metastatic pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 97, doi. 10.1007/s00280-013-2323-6
- By:
- Publication type:
- Article
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 151, doi. 10.1007/s00280-013-2333-4
- By:
- Publication type:
- Article
The effect of chemotherapy with cisplatin and pemetrexed for choroidal metastasis of non-squamous cell carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 199, doi. 10.1007/s00280-013-2341-4
- By:
- Publication type:
- Article
Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 213, doi. 10.1007/s00280-013-2351-2
- By:
- Publication type:
- Article
Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 87, doi. 10.1007/s00280-013-2322-7
- By:
- Publication type:
- Article
Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 125, doi. 10.1007/s00280-013-2328-1
- By:
- Publication type:
- Article
Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 139, doi. 10.1007/s00280-013-2332-5
- By:
- Publication type:
- Article
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 171, doi. 10.1007/s00280-013-2338-z
- By:
- Publication type:
- Article
Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 191, doi. 10.1007/s00280-013-2340-5
- By:
- Publication type:
- Article
Toll-like receptor signaling regulates cisplatin-induced mechanical allodynia in mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 25, doi. 10.1007/s00280-013-2304-9
- By:
- Publication type:
- Article
A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF mutation-positive metastatic melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 103, doi. 10.1007/s00280-013-2324-5
- By:
- Publication type:
- Article
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 181, doi. 10.1007/s00280-013-2339-y
- By:
- Publication type:
- Article
Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 35, doi. 10.1007/s00280-013-2314-7
- By:
- Publication type:
- Article
Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 131, doi. 10.1007/s00280-013-2329-0
- By:
- Publication type:
- Article
A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 17, doi. 10.1007/s00280-013-2290-y
- By:
- Publication type:
- Article
Mechanisms of action of tasquinimod on the tumour microenvironment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 1, doi. 10.1007/s00280-013-2321-8
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 61, doi. 10.1007/s00280-013-2317-4
- By:
- Publication type:
- Article
Peptide-based inhibition of the HOXA9/PBX interaction retards the growth of human meningioma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 53, doi. 10.1007/s00280-013-2316-5
- By:
- Publication type:
- Article
Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 69, doi. 10.1007/s00280-013-2318-3
- By:
- Publication type:
- Article
Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 79, doi. 10.1007/s00280-013-2319-2
- By:
- Publication type:
- Article